| Ticker Symbol: | SGP |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 2000 Galloping Hill Road Kenilworth 07033 908 298-4000 |
| CEO/President: | Fred Hassan |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Schering-Plough Corporation and its subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. The company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the company has sought regulatory approval to switch prescription products to over-the-counter status as a means of extending a product's life cycle. |
| Shares Outstanding: | 1,621,410 (000) | Market Value: | 24,497,670 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 82.59% | Number of Inst.Shareholders: | 0.66% |
| Last Quarter Sales: | 4921.00 ($Mil.) | Last Quarter Net Income: | 436.00 ($Mil.) |
| Last Quarter EPS: | 0.45 | P/E Ratio: | 10 |
| Most Recent Earnings: | 0.45 on 07/21/08 | Earnings Per Share: | -1.24 |
| Most Recent Split: | 2-1 on 12/03/98 | Annual Dividend Rate: | .26 |
| Most Recent Dividend: | 0.065 on 07/30/08 | Annual Dividend Yield: | 1.73% |


| PFIZER INC | -37.60 | 15.67 | |
| JOHNSON AND JOH | -16.00 | 57.58 | |
| MERCK CO INC | -54.70 | 26.21 | |
| BRISTOL MYERS S | -37.60 | 17.98 | |
| SCHERING PLOUGH | -56.60 | 13.87 |
